Jonathan Stephen Mason

This inventor holds 16 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Heptares Therapeutics Limited, Nxera Pharma UK Limited. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Stephen Mason. Retrieved from https://idiyas.com/inventor/jonathan-stephen-mason

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

Welwyn Garden City, GB (2017 - 2019)
Welwyn Garden, GB (2017 - 2019)
Walmer, GB (2014 - 2021)
Cambridge, GB (2019 - 2024)

Company Filing History:

12 out of 85

Heptares Therapeutics Limited

patents

4 out of 18

Nxera Pharma UK Limited

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

CGRP Antagonists

Triazolone Compounds

Triazine Derivatives

Cancer Treatment

Pharmaceuticals

Chemical Compounds

Drug Development

Therapeutics

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552799 - Triazolone compounds (2026-02-17),

2. 12528815 - 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer (2026-01-20),

3. 12178813 - CGRP receptor antagonists (2024-12-31),

4. 12054472 - 1,2,4-triazine-4-amine derivatives (2024-08-06),

5. 10988455 - 1,2,4-triazine-4-amine derivatives (2021-04-27),

6. 10888561 - CGRP receptor antagonists (2021-01-12),

7. 10300056 - CGRP receptor antagonists (2019-05-28),

8. 10259812 - CGRP receptor antagonists (2019-04-16),

9. 10166226 - CGRP receptor antagonists (2019-01-01),

10. 10112923 - 1,2,4-triazine-4-amine derivatives (2018-10-30),

11. 9925178 - CGRP receptor antagonists (2018-03-27),

12. 9808457 - CGRP receptor antagonists (2017-11-07),

13. 9802935 - CGRP receptor antagonists (2017-10-31),

14. 9688660 - CGRP receptor antagonists (2017-06-27),

15. 9249130 - 1,2,4-triazine-4-amine derivatives (2016-02-02),

Title: Jonathan Stephen Mason - Innovative Inventor from Walmer, GB

Introduction: Jonathan Stephen Mason is a renowned inventor hailing from Walmer, Great Britain. With a passion for creativity and problem-solving, he has made significant contributions to the field of innovations.

Latest Patents: Jonathan Stephen Mason holds several patents in various industries, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his career, Jonathan Stephen Mason has been recognized for his groundbreaking inventions that have revolutionized different sectors. His commitment to pushing boundaries and exploring new ideas has led to the development of cutting-edge technologies.

Collaborations: Jonathan Stephen Mason has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has resulted in successful projects and groundbreaking innovations.

Conclusion: Jonathan Stephen Mason's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in Walmer, GB, and beyond. His contributions continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.